标签归档 上海贵族宝贝交流

　　Proposed by China Petrochemical Co., Ltd. and drafted by Research Institute of Petrochemical Technology, the first national standard of biodiesel in China, Biodiesel for Diesel Fuel Blending, entered the approval process. The original biodiesel standards in China are all enterprise standards. The index setting and specific requirements of these standards are often formulated by enterprises according to their respective R&D, production and process levels, lacking common requirements. Some enterprises also directly adopt the standard of mineral diesel to produce biodiesel, but the composition and properties of biodiesel and mineral diesel are different, so controlling the quality of biodiesel with the standard of mineral diesel will cause many problems.
　　
　　Biodiesel is a real green energy, and the industrialization of biodiesel in China is in its infancy, facing many problems. Among them, there must be a basic answer to what requirements biodiesel needs to meet, which is exactly the question to be answered in "Biodiesel for Diesel Fuel Blending".
　　
　　In recent years, the international crude oil price has been soaring all the way, which is accompanied by the rapid economic growth and rising crude oil consumption in China. According to some sources, it is conservatively estimated that the national diesel shortage has reached 50 million tons every year. In the market, demand is the driving force. As early as when the international crude oil price just showed signs of rising, some domestic enterprises began to research and develop economic and environmental-friendly raw materials, so biodiesel began to move to the foreground.
　　
　　Biodiesel industry is easily accepted by the market because of its high technical maturity and good compatibility with existing oil transportation and distribution facilities. Although it can’t completely replace petrochemical diesel, it is still strongly supported because of its various advantages.
　　
　　However, although the technical path is feasible and countries such as Europe and America have been developing and encouraging the use of biodiesel, the industrialization of biodiesel in China, which is in its infancy, is also facing many problems. The national standard "Biodiesel for Diesel Fuel Blending" is trying to solve these problems, which will be of great significance to promote the industrialization of biodiesel.
　　
　　National standard of biodiesel: stand on tiptoe to reach it.
　　
　　According to Professor Zhang Yongguang, the drafter of the national standard of Biodiesel for Diesel Fuel Blending and director of the fuel oil products and additives research office of the Research Institute of Petrochemical Technology, the national standard of biodiesel in China includes 17 technical requirements and limits, namely, density: 0.82 ~ 0.90 kg/m3; The minimum value of kinematic viscosity is 1.9mm2/s and the maximum value is 6.0mm2/s; Flash point above 130℃; Cold filter points are reported; Set two indicators for sulfur content, namely, no more than 0.05% and 0.005%; 10% of the residual carbon of the steam residue is not more than 0.3%; Sulfate ash content is not more than 0.02%; Water content 0.05%; No mechanical impurities are allowed; Copper corrosion is not greater than grade 1; Cetane number is not less than 49; The oxidation stability is not less than 6.0; The acid value is not more than 0.80; Free glycerol does not exceed 0.02%; Total glycerol does not exceed 0.24%; 90% recovery temperature does not exceed 360℃. These requirements take into account that the use of biodiesel in China is mainly blended with ordinary mineral diesel in the proportion of 5% ~ 20% as a component fuel. If 100% biodiesel is used, it is necessary to formulate another standard or adjust the index requirements of this standard.
　　
　　In terms of the number of indicators, there are more than 10 differences between China’s biodiesel standards and developed countries, and the specific limits are also different. Zhang Yongguang explained that the main reason is that the raw materials of biodiesel in Europe and America are mainly oil crops. Simply taking their indicators will limit the raw materials of biodiesel in China, and some indicators are not in line with China’s situation. China’s national standard for biodiesel is a relatively high standard. According to the reality of most biodiesel production enterprises in China, it is necessary to stand on tiptoe to reach the standard.
　　
　　When making biodiesel standards, Chinese enterprises mostly refer to the indicators and specific requirements stipulated by foreign biodiesel standards. For some items that are not stipulated in the national standard of biodiesel in China, Zhang Yongguang explained that high concentrations of monoglyceride, diglyceride and triethylene glycol can produce injector deposits, which may affect the low-temperature operation performance and cause filter blockage. In the process of standard formulation, after analyzing the samples of Chinese enterprises, it is found that these three indicators are far less than the limits stipulated by European standards. At the same time, as blended biodiesel, monoglyceride, diglyceride and triethylene glycol can also play the role of lubricating additives in diesel, so these three indexes are not limited in Chinese standards. Residual metals can lead to engine deposition and wear, and pump and injector failure, which increases the smoke emission of diesel vehicles and makes it difficult to start. Monovalent metals and divalent metals can be introduced into the reaction by the catalyst of transesterification. Because the metal elements have been separated from biodiesel in the post-treatment, their content in biodiesel is generally small, so it is unnecessary to limit the metal content. Phosphorus can destroy the catalytic converter used in emission control system, and its content must be kept low. Because the phosphorus content of biodiesel in China is far less than that of biodiesel in Europe and America, the standard of biodiesel in China does not require phosphorus content. Iodine value is the number of grams of iodine consumed when reacting with 100 grams of oil under specified conditions. Biodiesel with high iodine value is unstable and easy to oxidize. However, the iodine value is only a rough estimate of the stability of biodiesel, so the iodine value is not required in China’s biodiesel standards.The methanol content in biodiesel is one of the unreacted residues in the production of biodiesel. The methanol content of biodiesel after treatment is generally low, and there is no equipment for detecting the methanol content of biodiesel in China at present, so the methanol content requirement is not included in the standard for the time being. The content of methyl ester reflects the degree of transesterification, and the EU standard requires no less than 96.5%. All the biodiesel samples taken in the process of standard formulation in China meet this requirement, so the Chinese standard does not require it.
　　
　　While people enjoy the convenience brought by automobiles, they also have to endure the environmental pollution and energy pressure caused by the development of automobile industry. Under the background of global warming and rising oil prices, finding alternative energy sources has become a common topic for the development of global automobile industry.
　　
　　Some experts pointed out that vigorously developing biomass energy to replace the increasingly scarce fossil energy is one of the directions of future energy development. In China, biodiesel is becoming a new field of biomass energy development. Focus on biomass energy: the industrialization of biodiesel is heating up.
　　
　　Biodiesel is a fatty acid monoalkyl ester prepared by transesterification of animal and vegetable oils with alcohols (such as methanol or ethanol). The raw materials of biodiesel mainly come from oil crops, oil trees and fruits, oil aquatic plants, animal fat, waste catering oil and so on. The commonly used oil crops are mainly soybeans and rapeseed, the fruits of oil trees are mainly oil palm and Pistacia chinensis, and oil aquatic plants mainly refer to engineering microalgae. These animal and vegetable oils and fats react with low-carbon alcohols such as methanol or ethanol in the presence of acid or alkaline catalyst and at a high temperature of 230~250℃ to produce fatty acid methyl ester or ethyl ester, which is then washed and dried to obtain biodiesel.
　　
　　Biodiesel was born in Germany in 1988. In 2005, the 15 member States of the European Union produced more than 2 million tons of biodiesel, accounting for 90% of the world’s total biodiesel. Germany is currently the country with the largest biodiesel production in the world.
　　
　　China began to produce biodiesel in 2001. At present, there are dozens of enterprises producing biodiesel in China, with an annual output of over 100,000 tons. China’s biodiesel is rich in raw materials. According to Chu Fuxiang, vice president of the Chinese Academy of Forestry, there are more than 600 common woody oil plants in China, with a total area of over 6.66 million hectares and an annual output of more than 2 million tons of seeds. Among them, there are dozens of kinds of seeds whose oil content reaches or approaches 50%, mainly including Jatropha curcas, Pistacia chinensis, light bark, Xanthoceras sorbifolia and so on. According to a study by the Bioenergy Research Center of Tianjin University, there is only one waste oil resource in China, with an annual output of 401,000 tons. The research and production of biodiesel in China is relatively late, but it has made rapid progress. From the distribution, selection, cultivation and genetic improvement of oil plants to the processing technology and equipment manufacturing, it has been industrialized. Companies in Hainan, Sichuan and Fujian have successively developed biodiesel production technologies with independent intellectual property rights, and successively built biodiesel production plants with a scale of over 10,000 tons. In 2005, the national special agricultural and forestry bioengineering project determined that the annual production capacity of biodiesel in China would reach 2 million tons by 2010 and 15 million tons by 2020.
　　
　　

On March 1, the movie "Zhou Chu Except for the Three Evils" Douban, which was launched in mainland theaters, achieved a score of 8.2 points, with excellent box office results. In just 5 days, the box office growth rate has exceeded that of the other three films in the Spring Festival.

The scale is not small, and the violent aesthetic is the first impression of many audiences of this film, but if only because of these two points, it is not enough to deserve the high evaluation of the film given by the audience. This crime action film directed by Huang Jingfu and starring Ruan Jingtian, Yuan Fuhua, Chen Yiwen, Wang Jing, Li Liren, Xie Qiong < unk > tells the story of Chen Guilin, a gangster killer who wanted to turn himself in, who was ignored by the police at the police station and decided to kill the two wanted criminals in front of him to get the sense of value he wanted.

The first thing that made "Zhou Zhuan Removal of the Three Evils" gain praise was Ruan Jingtian’s increasingly mature acting skills. He was no longer a young man who starred in "Monga". At the same time, this time, Chen Guilin saved Ruan Jingtian from the audience goodwill he lost when he starred in "Fu Yao".

Due to the plot and makeup of "Fu Shake", his audience’s popularity has dropped a lot. The makeup of "Fu Shake" really wants Ruan Jingtian to stay in his comfort zone. The story is also about love and male condensation, and the story of the pseudo-heroine is not pleasant.

Chen Guilin’s prototype is the legendary killer of the Taiwanese gang Liu Huanrong. At the beginning of the film, Chen Guilin appears at the funeral of the gang boss, eating a box lunch and chatting happily with others. After waiting for the target to appear, he leisurely walks forward and shoots people in front of everyone. After the high-profile murder, he also successfully shakes off the police and flees the scene.

In the movie, he would hold back tears because he was worried about his grandmother’s condition. Facing the half-naked Xiaomei, he would first put on a blanket for her. When he saw Xiaopang spitting black water, he immediately picked him up for medical treatment.

He successfully portrays a complex character like Chen Guilin, revealing the character’s inner world and emotional changes through delicate performances. Ruan Jingtian’s fist-to-meat fight in the movie is equally exciting, and the long-distance chase scene is also enjoyable to watch.

The performance of the other characters in the movie was equally wonderful. In the prison visit scene, the actor Xie Qiong sat like that, and the memories of the vicissitudes of his life were deeply felt. Wang Jing was worthy of being a powerful young actor.

As the Aberdeen actor Yuan Fuhua played the moody and ruthless character of the fugitive, Chen Yiwen played the Venerable with a smile. Tsang Peiyu, who played the Venerable Lover, was sometimes more like the Venerable One than the Venerable One. During the movie, when the Venerable One died and she didn’t run away, she had to play her role, making people feel that she was the boss behind the scenes.

The second highlight is that the plot of the movie is ironic enough. At the beginning of the movie "Removing the Three Harmies in Zhou Chu", each person is given 300 yuan for the appearance fee, which hints at the decline of the Taiwanese gangs, and the spiritual center also satirizes some organizations that generate electricity with love on the surface and speak noble slogans, but in fact are all kinds of dirty and hate organizations behind the scenes. In the movie, the cult killing scene in Zhou Chu is impressive. Chen Guilin is sitting leisurely changing bullets, and the people on the stage are still singing cult songs. Under the bright and warm sun, Chen Guilin is holding a gun and shooting people who have been brainwashed to the point of no return.

The third point is the drama of the story. After Xiaomei was rescued by Chen Guilin from Aberdeen’s hands, Chen Guilin asked her why her mother chose to take the blame for Aberdeen and imprisoned for 15 years. She said that her mother was also rescued by Aberdeen that year. At the beginning, Zhang Guiqing said that Chen Guilin had lung cancer, and in the movie, Chen Guilin kept coughing because of strong psychological suggestions, but at the end of the movie, the person who got lung cancer was actually Zhang Guiqing.

"The Three Harms" is also a movie full of details. The three most wanted criminals correspond to the greedy pigeons, snakes, and pigs, and the watch pattern bought by Chen Guilin’s grandmother is a piglet. The movie also deeply explores the essence of traditional Chinese culture. In the movie, we can see elements such as Guan Gong and the Holy Grail.

In an interview, Mr. Ruan said: "The movies and characters I have encountered in the past year or two have largely forced me to face the loneliness and weakness I had in the past, and forced me to face the unbearable things I had in the past." Regarding the 40-year-old period, he said: "I am also very happy to draw," and hope that Ruan Jingtian will bring us better works in the future.

In July, the trade of Chinese herbal medicines should have entered the off-season, but this year, the price has remained high since the beginning of the year.

　　In addition to the natural climate and other factors, many people in the industry pointed out that the intervention of hot money is the main reason to promote the current round of high prices of Chinese herbal medicines. Lily li, Secretary-General of Chinese Herbal Pieces Branch of Sichuan Pharmaceutical Industry Association, said that generally speaking, the price increase of Chinese herbal medicines is cyclical, and the price increase of individual varieties is more common. But this year, Ophiopogon japonicus, Codonopsis pilosula and Bulbus Fritillariae Cirrhosae, which are widely used in traditional Chinese medicine, are on the rise, and Cordyceps sinensis, which has a high unit price, has also increased by 30% compared with the same period last year. According to his rough statistics, among more than 300 commonly used varieties of Chinese herbal medicines, 200 have different increases.

　　"At present, it is obvious in the market that Chinese herbal medicines are driving up prices." Liu Xu, a special researcher of Tsinghua University National Institute of Strategic Studies, told the Chengdu Business Daily-Red Star journalist that relevant departments can investigate some malicious speculation and hoarding according to the price law and anti-monopoly law.

　　"I haven’t seen this kind of increase in 40 years."

　　More than 200 medicinal materials have increased by more than 50%, and some drug dealers have lost money to deliver.

　　Under the influence of high temperature and rain, June and July are generally regarded as the off-season of Chinese herbal medicine trading in the industry. However, this year, the prices of various Chinese herbal medicines have remained high since the beginning of the year. "Commonly used large varieties of medicinal materials are on the rise, and local angelica has risen from one kilogram in 60 yuan to one kilogram in 200 yuan; One kilogram of codonopsis pilosula in 80 yuan has now risen to 220 yuan, and Shayuanzi has increased tenfold. " An old Chinese doctor in the Southwest Chinese Medicine Clinic lamented: "It’s not normal. I have never seen this kind of increase in Chinese medicine for 40 years."

　　The business of the Chinese herbal medicine market has also been affected. In Qingping Chinese herbal medicine wholesale market, the price of Angelica sinensis has risen to 300 yuan per kilogram. Mr. Li of Qingping Market Medicinal Materials Company told Chengdu Business Daily-Red Star News reporter that since the price increase, the business has also become weak. According to Mr. Li’s estimation, the wholesale volume of angelica in the store has fallen by more than half.

　　From the origin and storage base of Chinese herbal medicines, to the wholesale market, and then to the whole industrial chain of Chinese herbal medicines entering hospitals and clinics, the impact of rising prices has been felt, and even some pharmaceutical companies that signed procurement contracts at the beginning of the year need to deliver at a loss. The person in charge of the pharmaceutical industry of a Chinese herbal medicine factory engaged in export business introduced that the Chinese herbal medicine factory generally measures the scale of procurement and production through customer orders. At the beginning of the year, after the factory prepared the annual consumption of about 20 tons of angelica for customers according to the practice of previous years, I didn’t expect to catch up with the price increase of angelica. Now there is still a gap of 5% to 10% of angelica in the factory. In order to deliver on time, the factory considers buying raw materials such as angelica at a high price. "A better decoction piece factory can only make a little profit, and some factories have to deliver when they lose money."

　　China association of traditional chinese medicine reported in June that in Bozhou, Anguo, Yulin and other major trading markets, more than 200 conventional varieties increased by more than 50% annually, 100 conventional varieties increased by more than 100% annually, and 25 commonly used bulk medicinal materials increased by more than 200% annually. The reporter checked the Chinese herbal medicine market of Chinese herbal medicine Tiandi. com and found that the prices of common Chinese herbal medicines such as Angelica sinensis, Bupleurum, Codonopsis pilosula, Glycyrrhiza uralensis, Astragalus complanatus, Paeonia lactiflora, Atractylodes macrocephala and Forsythia were among the top gainers.

　　On July 12th, lily li, Secretary-General of Chinese Herbal Pieces Branch of Sichuan Pharmaceutical Industry Association, also told reporters that generally speaking, wholesale channels (such as Chinese herbal medicine purchasing terminal and Chinese herbal pieces factory) are the first to feel the price increase of Chinese herbal medicines. "The most fierce rise is the unified angelica, which has probably increased by 260% so far."

　　Who is the "initiator"

　　People in the industry call the influx of hot money speculation, "like stock speculation."

　　What is the reason for the price increase of Chinese herbal medicines? According to lily li, from the analysis of natural climate, reducing production is one of the reasons leading to the price increase. Affected by high temperature and other factors, the bolting rate of Angelica sinensis is high, and the leaves are long and the roots are not long, which affects the quality and yield of the effective parts of the roots. After the planting cost increases, growers switch to other Chinese herbal medicines, resulting in reduced production.

　　A Chinese herbal medicine dealer in Min County, Gansu Province, the main producing area of Angelica sinensis, also told reporters that when the market was good, the yield of Angelica sinensis per mu was 400 kg/mu, compared with only a few tens of kg last year, because the bolting rate of Angelica sinensis seedlings was too high. "The cost of an acre of land has also risen from more than 2,000 to more than 10,000, and many growers don’t want to plant it."

　　Lily li pointed out that in recent years, the output of Chinese herbal medicines has decreased, while the processing cost and manpower transportation cost of Chinese herbal pieces factory are increasing.

　　In addition, many people in the industry pointed out that hot money is the main driver of the current round of high prices of Chinese herbal medicines. Lily li also introduced that, generally speaking, the price increase of Chinese herbal medicines is cyclical, and the price increase of individual varieties is more common. But this year, the consumption of Ophiopogon japonicus, Codonopsis pilosula, Astragalus membranaceus and Fritillaria cirrhosa is increasing, and Cordyceps sinensis, which has a high unit price, has also increased by 30% compared with the same period last year. According to rough statistics, among more than 300 commonly used varieties of Chinese herbal medicines, 200 have different increases.

　　Jia Haibin, Deputy Secretary-General of the Special Committee for Breeding of Chinese Medicine Association, said in an interview that since the second half of 2020, the domestic prices of Chinese herbal medicines have started to enter a continuous rising channel, with a large increase and a long rising cycle, which is extremely rare in the history of Chinese herbal medicines with data records. Jia Haibin said that in the past three years, the prices of many varieties such as Shayuanzi, Longgu, Guanhuangbai and Ziziphus jujuba have doubled. "Whether it is the planting area or the weather, there are data to check, which are within the normal range. The price increase of Chinese herbal medicines in this round is not normal. "

　　"It’s the funds that enter the market to stock up and speculate, which is as high as stock trading." A dealer who has been receiving goods in Gansu, Qinghai, Henan and other traditional Chinese medicines for many years revealed that, just like the speculation of Sanqi more than a decade ago, many capitals chose several traditional Chinese medicines with relatively concentrated production areas, such as Angelica sinensis, Codonopsis pilosula, Astragalus membranaceus, etc.: "The way of speculation is to give money without picking up the goods, but only to speculate among various frozen warehouses."

　　According to the president of Yuzhou Pharmaceutical Chamber of Commerce, when he went to the country of origin to get medicine this year, he found many unfamiliar faces, many of whom were real estate bosses or coal bosses. After purchasing medicinal materials, they all hoarded them, and the lower they went, the higher they went. "In April this year, I went to Shanxi to purchase medicinal materials, and I happened to meet a coal boss who was also purchasing. He bought hundreds of tons of a variety of Bupleurum. "

　　Bozhou, Anhui Province is the base with the largest storage capacity of Chinese herbal medicines in China. When the reporter randomly asked whether there were any remaining medicinal materials in several freezers in Bozhou on the grounds of wholesaler’s inventory, many cold storage staff said that there were no vacancies. "The cold storage is basically medicinal materials, and there are fewer warehouses, and the storage price has nearly doubled."

　　"At present, it is obvious in the market that Chinese herbal medicines are driving up prices." After comprehensive analysis, Liu Xu thinks that apart from weather and other reasons, most of the reasons are that wholesalers are jointly hoarding &mdash; &mdash; Because the purchasing ability, storage ability and sales ability of a single wholesaler are limited, once a large wholesaler takes the lead in releasing inventory in multiple categories, the whole price can come down. However, the current situation is that Chinese herbal medicines have continued to rise and run at a high level since the beginning of the year. "Without collusion between wholesalers, it is difficult to achieve." To this end, Liu Xu has repeatedly said, "It is suggested to investigate whether there is hoarding speculation and conspiracy to price behind the rising prices of Chinese herbal medicines year after year."

　　Industry moves to contain

　　The Chinese Medicine Association called for the prohibition of price gouging and the launch of the "Chinese Medicine Production and Marketing Consortium Action"

　　Major medical associations in China have also voiced their voices. Since June, the Professional Committee of Chinese Herbal Pieces of Jiangsu Pharmaceutical Industry Association, Guangdong Pharmaceutical Industry Association and Bozhou Chinese Herbal Pieces Industry Promotion Association have submitted the Report on Abnormal Market Price Growth of Chinese Herbal Medicines to china association of traditional chinese medicine successively, arguing that there are social hot money or dealers who jointly hoard Chinese herbal medicines, and the prices of Chinese herbal medicines have soared abnormally.

　　On June 22nd, china association of traditional chinese medicine reported to state administration of traditional chinese medicine the "Investigation Report of china association of traditional chinese medicine on the Recent Abnormal Price Rise of Chinese Herbal Medicines", calling on relevant state departments to issue policies and take effective measures to maintain the market price stability of Chinese herbal medicines and ensure the healthy, orderly and high-quality development of the Chinese medicine industry.

　　On July 8, china association of traditional chinese medicine once again issued a proposal to all units, saying that the market of Chinese herbal medicines has been fluctuating abnormally recently, and resolutely opposed and never participated in any improper or even illegal acts that disrupted the market order of Chinese herbal medicines, such as price gouging and manipulation, speculation and speculation.

　　On July 11th, Shandong Internet Traditional Chinese Medicine (Materials) Trading Center issued the "Initiative on Promoting Direct Supply and Direct Sale of Chinese Herbal Medicines and Pieces and Curbing Unreasonable Price Increase", saying that some medicinal materials have been brought with strong financial attributes, and the healthy development of the industry has been seriously impacted. Behind this round of sustained price increase, the reasons are not only the imbalance between supply and demand of some varieties, the reduction of production due to weather, and the improvement of drug standards, but also the wanton speculation of hoarders, which further aggravates the imbalance between supply and demand. Shandong Internet Chinese Medicine (Materials) Trading Center decided to launch the "Chinese Medicine Production and Marketing Consortium Action" to ensure the direct supply of Chinese herbal medicines and pieces.

　　The regulatory system of traditional Chinese medicine faces challenges

　　Experts suggest public investigation.

　　According to Cao Haibin, deputy secretary-general of the Special Committee of Breeding and Breeding of Chinese Medicine Association, this price increase is undoubtedly a challenge to the current Chinese medicine supervision system. The reasons for this round of soaring prices of Chinese herbal medicines are extremely complicated, and it is urgent to improve the top-level structure and reconstruct the industrial interest pattern.

　　Liu Xu believes that relevant departments can investigate malicious speculation and hoarding according to the price law and anti-monopoly law. "If there is collusion, information exchange and collaboration between wholesalers of Chinese herbal medicines, it is equivalent to a monopoly agreement, and the anti-monopoly law should be applied to regulate it. If it is independent decision-making, you can also consider applying the price method. Because the price law applies to all acts of arrogance and hoarding, the two laws can be said to be complementary. "

　　Liu Xu introduced that Chinese herbal medicines have not received enough attention because of their scattered origin and market and long-term free competition. However, this year’s rally has not only appeared in one area, but more than 100 kinds of Chinese herbal medicines have increased in price in Anhui, Gansu, Henan, Chongqing and even the whole country. "From the perspective of anti-monopoly law enforcement, even if one of the 100 Chinese herbal medicines is due to hoarding and price increase, it is also a punishment." Liu Xu said.

　　Liu Xu pointed out that, generally speaking, the public concern or organization warning of law enforcement agencies will have a deterrent effect on all kinds of price manipulation in the market. However, in order to help the Chinese herbal medicine industry to restore normal market competition, it is necessary to open a case for investigation in a timely and decisive manner, severely punish monopolistic behavior and price violations according to law, and confiscate illegal income, so as to make an example for others. Only with stable drug prices and sufficient supply can growers, wholesalers, Chinese herbal medicine enterprises and medical enterprises in the industrial chain form reasonable expectations, and the Chinese herbal medicine industry can achieve long-term healthy development.

　　A positive signal is that china association of traditional chinese medicine said recently that the Association is cooperating with the competent authorities to carry out an investigation on the price issue.